News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novo Nordisk A/S (NVO) Files Annual Report With the SEC


2/7/2013 9:28:07 AM

BAGSVAERD, DENMARK--(Marketwire - February 07, 2013) - Novo Nordisk A/S has filed its Annual Report 2012 on Form 20-F for the financial year 2012 with the US Securities and Exchange Commission (SEC), incorporating by reference parts of the Novo Nordisk A/S Annual Report 2012. The reports are available at the SEC's website, www.sec.gov as well as on novonordisk.com.

Shareholders and ADR holders may receive a hard copy of the annual reports free of charge upon request by filling out a request form on novonordisk.com or upon request to either Tel: (+1) 609 786 4575 or by e-mail to jlis@novonordisk.com. When e-mailing, please state the exact mailing address and the document(s) you wish to receive.


Read the full release in PDF format: http://hugin.info/2013/R/1676306/546328.pdf


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1676306]


Further information:


Media:

Anne Margrethe Hauge
+45 4442 3450
Email Contact


Investors:

Kasper Roseeuw Poulsen
+45 4442 4303
Email Contact

Frank Daniel Mersebach
+45 4442 0604
Email Contact

Lars Borup Jacobsen
+45 3075 3479
Email Contact

Jannick Lindegaard (US)
+1 609 786 4575
Email Contact


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES